National Cancer Center Hospital (NCCH)

Chuo-Ku, Tokyo

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer — Completed